Company Description
Danimer Scientific, Inc., a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally.
It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.
The company products are used in various applications, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles.
It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry.
Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
Country | United States |
Founded | 2004 |
Industry | Specialty Chemicals |
Sector | Materials |
Employees | 257 |
CEO | Stephen E. Croskrey |
Contact Details
Address: 140 Industrial Boulevard Bainbridge, Georgia 39817 United States | |
Phone | 229-243-7075 |
Website | danimerscientific.com |
Stock Details
Ticker Symbol | DNMR |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001779020 |
CUSIP Number | 236272100 |
ISIN Number | US2362721001 |
Employer ID | 84-1924518 |
SIC Code | 2821 |
Key Executives
Name | Position |
---|---|
Richard J. Hendrix | Interim Executive Chairman |
Stephen E. Croskrey | Chief Executive Officer and Director |
Michael A. Hajost | Chief Financial Officer |
Scott C. Tuten | Chief Marketing and Sustainability Officer |
Michael Smith | Chief Operating Officer |
Russ Zukowski | Vice President of Corporate Finance |
Phillip D. Van Trump | Chief Science and Technology Officer |
James Palczynski | Investor Relations Officer |
Stephen Albert Martin Esq. | Corporate Secretary and Chief Legal Officer |
Anthony L. Austin | Chief Human Resource Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 30, 2024 | ARS | Filing |
May 30, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
May 30, 2024 | DEF 14A | Other definitive proxy statements |
May 24, 2024 | 424B3 | Prospectus |
May 24, 2024 | 8-K | Current Report |
May 24, 2024 | 424B3 | Prospectus |
May 20, 2024 | PRE 14A | Other preliminary proxy statements |
May 20, 2024 | 8-K | Current Report |
May 13, 2024 | S-3 | Registration statement under Securities Act of 1933 |
May 10, 2024 | 424B3 | Prospectus |